Extracranial Head and Neck Neoplasms: Role of Imaging

Petrou, M.D. Ilya; Mukherji, Suresh K.

doi:10.1007/978-0-387-75587-8_4

Cited by 3 publications

(2 citation statements)

References 68 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Both CT scanner and magnetic resonance imaging (MRI) are giving highly relevant information about location, size, shape, and contours of the primary tumor [49]. The two modalities have specific advantages but also suffer from significant limitations: 'fast' CT is able to freeze motion artefacts and has the unsurpassed advantage in yielding information about electron density, useful for RT planning.…”

Section: Challenges and Perspectives In Imaging Work-upmentioning

confidence: 99%

Advances in the management of squamous cell carcinoma of the head and neck

Machiels¹,

Lambrecht²,

Hanin³

et al. 2014

F1000Prime Rep

View full text Add to dashboard Cite

Squamous cell carcinoma of the head and neck (SCCHN) is the sixth most common cancer worldwide. The main risk factors for cancers of the oral cavity, larynx, oropharynx, and hypopharynx are alcohol and tobacco use. In addition, the human papillomavirus (HPV) is an established cause of oropharyngeal cancer. An experienced multidisciplinary team is necessary for adequate management and optimal outcome. The treatment of locally advanced disease generally requires various combinations of radiotherapy, surgery, and systemic therapy, but despite this aggressive multimodal treatment, 40% to 60% of the patients will relapse. In this report, we will discuss recent advances in the management of SCCHN, including new developments in molecular biology, imaging, and treatment.

show abstract

Section: Challenges and Perspectives In Imaging Work-upmentioning

confidence: 99%

Advances in the management of squamous cell carcinoma of the head and neck

Machiels¹,

Lambrecht²,

Hanin³

et al. 2014

F1000Prime Rep

View full text Add to dashboard Cite

show abstract

“…The wide-spread use of flexible endoscopic examination in the out-patient department is adequate in most instances to visualise correctly the craniocaudal extent of a tumour with CT or MRI completing the clinical staging. 13,14 The use of PET/CT in patients with newly diagnosed head and neck cancer demonstrates a high positive predicative value in detecting simultaneous lesions and further limits the need for EUAP. [15][16][17] …”

Section: Discussionmentioning

confidence: 99%

The Use of Examination Under Anaesthesia and Panendoscopy in Patients Presenting with Oral Cavity and Oropharyngeal Squamous Cell Carcinoma

Kerawala

Bisase

Lee

2009

annals

View full text Add to dashboard Cite

INTRODUCTION Although examination under anaesthesia and panendoscopy (EUAP) has traditionally been used in the assessment of patients presenting with oral cavity and oropharyngeal squamous cell carcinoma (SCC), the era of modern medicine with its advanced imaging techniques has meant that the indications for this technique have potentially reduced. SUBJECTS AND METHODS In an attempt to quantify the current use of EUAP in the UK, a structured telephone questionnaire was undertaken of 50 maxillofacial units. Information was gathered regarding whether the technique was adopted on a routine or selective basis. Likewise perceived disadvantages were sought. RESULTS Twenty-two units (44%) carried out EUAP on all patients presenting with oral cavity and oropharyngeal SCC. Of the remaining 28 units, all employed EUAP on a selective basis, the most commonly for the assessment of the primary tumour. The most common perceived disadvantage of carrying out EUAP routinely was its potential to increase the waiting time to definitive treatment. CONCLUSIONS These results suggest a gradual move towards the selective use of EUAP in patients presenting with oral cavity and oropharyngeal SCC. KERAWALA BISASE LEE EUAP IN ORAL CAVITY AND OROPHARYNGEAL SQUAMOUS CELL CARCINOMA PATIENTSAnn R Coll Surg Engl 2009; 91: 609-612 610 on a selective basis. For the purposes of the study 'panendoscopy' was defined as the endoscopy of the nasal cavity, nasopharynx, oropharynx, larynx and upper oesophagus, with or without bronchoscopy. The indications for EUAP were obtained in terms of index tumour assessment, detection of simultaneous disease in the asymptomatic individual and its use as a 'test anaesthetic'. In units with a selective approach, further information regarding that process was elicited, e.g. did a patient's exposure to risk factors influence its use? Finally, the perceived advantages of EUAP were obtained where relevant. ResultsRepresentatives from 50 maxillofacial units were questioned. Of these, 22 (44%) employed EUAP on all patients. Of the remaining 28 units, the most common indication for EUAP was the assessment of the index tumour (Fig. 1). Around one in four units still felt that the use of EUAP as a 'test anaesthetic' was justified.For those units adopting a selective approach, the most commonly perceived disadvantage of routine EUAP was a potential increase in waiting time to definitive treatment (Fig. 2). One-third of units also expressed concern regarding the cost implications of a second anaesthetic. DiscussionEUAP was introduced in the management of head and neck malignancy in the late 1970s and is still used in many units throughout the world on a routine basis. It requires little in the way of equipment and remains less expensive than some of the alternative modes of staging patients such as computed tomography (CT), magnetic resonance imaging (MRI) and positron imaging tomography. The morbidity and mortality is low.1 In this day and age, it may still be the most sensitive way of detecting superficial mucosal ...

show abstract